Back to search

Article

CDK5/CAMK2-DRP1-AMPK-Mediated Mitochondrial Fission is Required for Imatinib Resistance of CML Cells

2020-08-06

Abstract excerpt

<h4>Background: </h4> In chronic myeloid leukemia (CML), resistance to tyrosine kinase inhibitors (TKIs) is still a serious clinical challenge, especially in the context of multi-resistance BCR-ABL mutations, such as T315I. Increasing evidence has demonstrated that mitochondrial fission plays an important role in cancer stem cell maintenance and drug resistance. Therefore, as a vital fission-related protein, DRP1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
669c47b9-6eb2-57a2-900c-60a78a72509b
DOI
10.21203/rs.3.rs-52123/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CDK5/CAMK2-DRP1-AMPK-Mediated Mitochondrial Fission is Required for Imatinib Resistance of CML CellsDOI 10.21203/rs.3.rs-52123/v1
Select a neighboring publication to make it the new centre.